5AM Venture Management, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$419.1B
Holdings
31
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TRDAENTRADA THERAPEUTICS INC | 4,408,379 | $76.2B | 18.19% | |
| 2 | ELVNENLIVEN THERAPEUTICS INC | 1,629,765 | $36.7B | 8.75% | |
| 3 | SKYESKYE BIOSCIENCE INC | 9,913,168 | $28.1B | 6.69% | |
| 4 | TECXTECTONIC THERAPEUTIC INC | 596,660 | $27.5B | 6.57% | |
| 5 | ARTVARTIVA BIOTHERAPEUTICS INC | 2,353,304 | $23.7B | 5.66% | |
| 6 | DNTHDIANTHUS THERAPEUTICS INC | 1,027,711 | $22.4B | 5.35% | |
| 7 | BHVNBIOHAVEN LTD | 478,972 | $17.9B | 4.27% | |
| 8 | PHVSPHARVARIS N V | 797,600 | $15.3B | 3.65% | |
| 9 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 282,313 | $15.3B | 3.65% | |
| 10 | CAMPCAMP4 THERAPEUTICS CORP | 2,927,915 | $15.3B | 3.65% | |
| 11 | VRDNVIRIDIAN THERAPEUTICS INC | 736,595 | $14.1B | 3.37% | |
| 12 | CNTACENTESSA PHARMACEUTICALS PLC | 830,945 | $13.9B | 3.32% | |
| 13 | ERASERASCA INC | 5,405,404 | $13.6B | 3.24% | |
| 14 | PRAXPRAXIS PRECISION MEDICINES I | 170,000 | $13.1B | 3.12% | |
| 15 | TYRATYRA BIOSCIENCES INC | 939,298 | $13.1B | 3.12% | |
| 16 | TCE2CELLDEX THERAPEUTICS INC NEW | 497,270 | $12.6B | 3.00% | |
| 17 | EYPTEYEPOINT PHARMACEUTICALS INC | 1,050,000 | $7.8B | 1.87% | |
| 18 | VKTXVIKING THERAPEUTICS INC | 189,593 | $7.6B | 1.82% | |
| 19 | VORVOR BIOPHARMA INC | 6,361,723 | $7.1B | 1.69% | |
| 20 | ANABANAPTYSBIO INC | 357,733 | $4.7B | 1.13% | |
| 21 | AKROAKERO THERAPEUTICS INC | 165,000 | $4.6B | 1.10% | |
| 22 | SCPHSCPHARMACEUTICALS INC | 1,200,647 | $4.3B | 1.01% | |
| 23 | TARAPROTARA THERAPEUTICS INC | 800,000 | $4.2B | 1.01% | |
| 24 | GHRSGH RESEARCH PLC | 572,665 | $4.0B | 0.96% | |
| 25 | RLYBRALLYBIO CORP | 3,630,724 | $3.5B | 0.83% | |
| 26 | SLNSILENCE THERAPEUTICS PLC | 476,200 | $3.3B | 0.78% | |
| 27 | AVU0ADVERUM BIOTECHNOLOGIES INC | 541,666 | $2.5B | 0.60% | |
| 28 | ALECALECTOR INC | 995,841 | $1.9B | 0.45% | |
| 29 | —MERSANA THERAPEUTICS INC | 1,305,000 | $1.9B | 0.45% | |
| 30 | CDTXCIDARA THERAPEUTICS INC | 56,725 | $1.5B | 0.36% | |
| 31 | ZNTLZENTALIS PHARMACEUTICALS INC | 490,000 | $1.5B | 0.35% |